EVELENA ONTIVEROS MD PHD NPI 1689886962

NPI Information

  • NPI: 1689886962
  • Provider Name: EVELENA ONTIVEROS, MD PHD
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 210 W MCKINLEY AVE STE 1
    DECATUR, IL
    ZIP 62526
  • Phone: (217) 876-6600

Map and Directions

Get Directions

NPI Details

Evelena Ontiveros, MD PHD is a hematology and oncology internal medicine in Decatur, IL with 22 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Evelena Ontiveros, MD PHD NPI is 1689886962. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: UNIVERSITY OF IOWA, RJ & L CARVER COLLEGE OF MEDICINE
Graduation Year:2004

The provider's business location address is:

210 W MCKINLEY AVE STE 1
DECATUR, IL
ZIP 62526-858
Phone: (217) 876-6600
Fax: (217) 876-6606

The NPI 1689886962 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, iron sucrose, 1 mg (HCPCS:J1756)
  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
  • Iron binding capacity (HCPCS:83550)
  • Iron level (HCPCS:83540)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Red blood cell concentration measurement (HCPCS:85014)
  • Blood count, hemoglobin (HCPCS:85018)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Magnesium level (HCPCS:83735)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Collection of blood sample from implanted device (HCPCS:36591)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Kidney function blood test panel (HCPCS:80069)
  • Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
  • Uric acid level, blood (HCPCS:84550)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Red blood count, automated test (HCPCS:85045)
  • Beta-2 microglobulin (protein) level (HCPCS:82232)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)
  • Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
  • Folic acid level, serum (HCPCS:82746)
  • Ct scan of chest without contrast (HCPCS:71250)
  • Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
  • Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
  • Blood creatinine level (HCPCS:82565)
  • Urea nitrogen level to assess kidney function, quantitative (HCPCS:84520)
  • Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
  • Vitamin d-3 level (HCPCS:82306)

The enumeration date for this NPI number is 5/7/2007 and was last updated on 11/12/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology036143984ILLINOISYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.